BackPrecigen Overview
Precigen Inc

Precigen Target Price

Analysts' average 12-month price target for Precigen is $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$7.1

Average Target Price

$14.33101.9% upside

3 analysts in the last 4 months

High: $18 | Low: $11

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-05H.C. Wainwright$18153.5% upsideOpen
2026-05-28H.C. Wainwright$1497.2% upsideOpen
2026-05-14H.C. Wainwright$1154.9% upsideOpen
2022-08-09H.C. Wainwright$615.5% downsideOpen

Precigen (PGEN) FAQ

Precigen (PGEN) currently reports a target price of $14. Use the charts on this page to explore Precigen's target price history and peer comparisons.

Analysts' average 12-month price target for Precigen is $14, about 101.9% upside from the current share price of $7.1. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $14, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Precigen, and consider following PGEN for alerts when major investors trade the stock.

Precigen is classified in the Healthcare sector. On target price, it currently shows $14. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PGEN with unrelated industries.